Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by TScan Therapeutics, Inc.
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
April 17, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
April 16, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
April 16, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
April 08, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 06, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
February 26, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
February 14, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
February 06, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
January 29, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR
January 18, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress
January 04, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
December 09, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
December 07, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition
December 04, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
December 04, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years
November 30, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting
November 06, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition
November 02, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting
September 27, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics to Participate in Upcoming Investor Conferences
September 05, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-203-A0201 Targeting PRAME
August 29, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 10, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Transition of Chief Financial Officer
June 29, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-200-A0201 Targeting HPV16 to Treat Solid Tumors
June 06, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting
June 01, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics Announces Closing of Public Offering
June 01, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
TScan Therapeutics to Participate in the Jefferies Healthcare Conference
June 01, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
TCRX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.